In the notice with the above heading, published in the New Zealand Gazette, 6 June 2019, Issue No. 2019-go2560, replace the notice with the following:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
IPCA-Enalapril
Enalapril maleate 5mg
Tablet
Ipca Pharma (NZ) Pty Limited
Ipca Laboratories Limited, Silvassa, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
IPCA-Enalapril
Enalapril maleate 10mg
Tablet
Ipca Pharma (NZ) Pty Limited
Ipca Laboratories Limited, Silvassa, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
IPCA-Enalapril
Enalapril maleate 20mg
Tablet
Ipca Pharma (NZ) Pty Limited
Ipca Laboratories Limited, Silvassa, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Lemtrada
Alemtuzumab 10mg/mL
Concentrate for infusion
Sanofi-Aventis New Zealand Limited
Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
|
Dated this 7th day of June 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz